Back
Grand Canyon Education Vs. PTC Therapeutics Industry Stock Comparison
Buy
62
LOPE
Grand Canyon Education
Last Price:
141.47
Seasonality Move:
1.77%
Sell
35
PTCT
PTC Therapeutics
Last Price:
31.21
Seasonality Move:
8.27%
Buy
62
Grand Canyon Education (LOPE)
is a Buy
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $139.97. The Score for LOPE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- LOPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $30.58. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $139.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $30.58
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.3 | Sell |
| Relative Strength Index (14 RSI): | 53.2 | Buy |
| Chaikin Money Flow: | 134397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (136.32 - 143.64) | Sell |
| Bollinger Bands (100): | (130.45 - 141.51) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 34.74 | Sell |
| Chaikin Money Flow: | 26543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.49 - 37.71) | Sell |
| Bollinger Bands (100): | (26.63 - 35.17) | Sell |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 135.94 | Buy |
| 20-day SMA: | 139.05 | Buy |
| 50-day SMA: | 139.17 | Buy |
| 200-day SMA: | 131.68 | Buy |
| 8-day EMA: | 136.96 | Buy |
| 20-day EMA: | 138.34 | Buy |
| 50-day EMA: | 138.47 | Buy |
| 200-day EMA: | 131.02 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.57 | Sell |
| 20-day SMA: | 36.04 | Sell |
| 50-day SMA: | 33.78 | Sell |
| 200-day SMA: | 27.65 | Buy |
| 8-day EMA: | 34.28 | Sell |
| 20-day EMA: | 35.15 | Sell |
| 50-day EMA: | 33.95 | Sell |
| 200-day EMA: | 31.82 | Sell |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.86 per share, and an increase next year of $0.85 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.10 per share, an increase this year of $0.53 per share, and an increase next year of $2.08 per share.
Grand Canyon Education Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||